Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Long intergenic non-protein coding RNA 2616 (LINC02616) is a non-coding RNA gene, part of the lincRNA family, which comprises RNA molecules longer than 200 nucleotides situated between protein-coding genes[5]. LincRNAs modulate gene expression via mechanisms such as chromatin remodeling, RNA stabilization, and transcriptional regulation[1][5]. While many lincRNAs are functionally important in numerous biological processes and some are implicated in disease, the precise role, disease associations, and therapeutic potential of LINC02616 have not been characterized. LINC02616 is currently annotated in major human gene databases, but lacks specific experimental literature describing its function, clinical relevance, or direct drug interactions.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Long intergenic non-protein coding RNA 2616 (LINC02616).